*By Carlo Versano* Over the last decade, as the ground underneath traditional retailers shifted, one segment of the market seemed averse to the changes. Luxury brands, unwilling to follow what was perceived as a downmarket strategy, sat back as Amazon ($AMZN) and direct-to-consumer upstarts chipped away at their customer base. But then came Farfetch ($FTCH), an online marketplace built exclusively for luxury retailers and their discerning customers. On Friday, Farfetch debuted to fanfare at the NYSE ー with shares priced above the range and jumping more than 50 percent at the highs of the day. CEO José Neves, a Portuguese entrepreneur who launched the company in 2008, told Cheddar that Farfetch has been an "enabler" of the luxury industry, forging partnerships directly with fashion houses as their exclusive digital marketplace. "We have been investing ahead of the curve," Neves said. London-based Farfetch offers access to over 600 retailers and 375 brands on its marketplace ー the vast majority are exclusive. Neves is perhaps less worried than other retail CEOs that his partners will turn to Amazon, largely because luxury brands have resisted putting their expensive, high-end products on a website where they might appear next to toilet paper or cat food. The company's ability to protect fashion houses against brand dilution has been key to its growth, Neves said. Additionally, as a sort of hedge against direct-to-consumer retailing, Farfetch has developed its own digital infrastructure, called "Black and White," which lets other brands create their own e-commerce sites using the platform. But for Neves, one of the most exciting opportunities in luxury retail is, paradoxically, brick-and-mortar, which he said "hasn't been touched by digital innovation." Though consumer habits have changed broadly, they have remained stubbornly constant in the high-end space ー customers in the market for a Gucci purse or Hermès scarf still like to go to the store to see it, touch it, and eventually buy it. Neves said he recognizes that the physical retail experience will probably always be critical to luxury shoppers, but his company is trying to nudge attitudes. Only 9 percent of luxury goods are currently sold online ー Neves thinks that could go as high as 25. To help get there, Farfetch is investing in technology to bring new life to stores for brands like Chanel. "It's the next big revolution in this industry," he said. "I'm a strong believer that brick-and-mortar is here to stay." Farfetch brought in more than $260 million in revenue in the first six months of the year, a 50 percent increase from a year ago, but has yet to turn a profit. It raised more than $800 million in its offering. The stock ended its first day of trading up more than 40 percent from its IPO price. For full interview [click here](https://cheddar.com/videos/farfetch-ceo-on-companys-blockbuster-ipo).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More